Geode Capital Management’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34M | Sell |
782,641
-53,054
| -6% | -$2.3M | ﹤0.01% | 1645 |
|
|
2025
Q1 | $31.2M | Buy |
835,695
+19,582
| +2% | +$732K | ﹤0.01% | 1648 |
|
|
2024
Q4 | $37M | Sell |
816,113
-7,726
| -0.9% | -$350K | ﹤0.01% | 1623 |
|
|
2024
Q3 | $48.4M | Buy |
823,839
+82,978
| +11% | +$4.87M | ﹤0.01% | 1448 |
|
|
2024
Q2 | $29.2M | Sell |
740,861
-20,163
| -3% | -$794K | ﹤0.01% | 1715 |
|
|
2024
Q1 | $50.6M | Buy |
761,024
+319,552
| +72% | +$21.2M | ﹤0.01% | 1350 |
|
|
2023
Q4 | $12.3M | Buy |
441,472
+40,236
| +10% | +$1.12M | ﹤0.01% | 2218 |
|
|
2023
Q3 | $8.55M | Buy |
+401,236
| New | +$8.55M | ﹤0.01% | 2363 |
|